WASHINGTON--The National Coalition for Cancer Research (NCCR)
has activated its 18 member organizations to write to Congress
in support of S.1897, the NIH Revitalization Act of 1996. This
legislation was introduced in the US Senate by Sen. Nancy Kassebaum
(R-KS) to revise and extend certain programs of the NIH, including
the National Cancer Institute (NCI).
The legislation authorizes funding for the NCI at $3 billion and
strikes various cancer-specific earmarks, ie, allocations for
breast cancer, ovarian cancer, and prostate cancer. The NCCR supports
a balanced cancer research agenda and believes that earmarking
of site- and gender-specific research should not be supported
unless additional funds are provided for these priorities.